Insiders · CPIX

CPIX insider transactions

Cumberland Pharmaceuticals Inc. (CPIX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CPIX

• 80d
  SEC Form 4 filed by Brown Martin S Jr

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Galante Joseph C

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Jones James

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Krogulski Kenneth

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Young Caroline

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Anthony Todd M.

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Bitterman Chris T.

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Hamm John M.

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Herman James L

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 80d
  SEC Form 4 filed by Kazimi A J

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 82d
  SEC Form 4 filed by Kazimi A J

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 153d
  Director Young Caroline increased direct ownership by 0.20% to 33,309 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 153d
  Director Jones James increased direct ownership by 0.60% to 45,063 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 153d
  Chairman and CEO Kazimi A J increased direct ownership by 0.00% to 5,701,155 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 153d
  Director Krogulski Kenneth increased direct ownership by 0.65% to 296,538 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 189d
  Director Young Caroline increased direct ownership by 0.23% to 33,243 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 189d
  Director Jones James increased direct ownership by 0.68% to 44,793 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 189d
  Chairman and CEO Kazimi A J increased direct ownership by 0.01% to 5,700,885 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 189d
  Director Krogulski Kenneth increased direct ownership by 0.69% to 294,622 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 217d
  Director Young Caroline increased direct ownership by 0.42% to 33,168 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 217d
  Director Jones James increased direct ownership by 0.68% to 44,491 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 217d
  Chairman and CEO Kazimi A J increased direct ownership by 0.01% to 5,700,583 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 217d
  Director Krogulski Kenneth increased direct ownership by 0.54% to 292,595 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 248d
  Director Young Caroline increased direct ownership by 0.27% to 33,030 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 248d
  Director Jones James increased direct ownership by 0.58% to 44,192 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 248d
  Chairman and CEO Kazimi A J increased direct ownership by 0.00% to 5,700,284 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 248d
  Director Krogulski Kenneth increased direct ownership by 0.45% to 291,031 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 269d
  Director Young Caroline bought $398 worth of shares (121 units at $3.29), increasing direct ownership by 0.37% to 32,942 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 269d
  Director Jones James bought $862 worth of shares (262 units at $3.29), increasing direct ownership by 0.60% to 43,938 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 269d
  Chairman and CEO Kazimi A J bought $862 worth of shares (262 units at $3.29), increasing direct ownership by 0.00% to 5,700,030 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 269d
  Director Krogulski Kenneth bought $4,516 worth of shares (1,372 units at $3.29), increasing direct ownership by 0.48% to 289,717 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 301d
  Director Young Caroline bought $578 worth of shares (168 units at $3.44), increasing direct ownership by 0.51% to 32,821 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 301d
  Director Jones James bought $1,166 worth of shares (340 units at $3.43), increasing direct ownership by 0.78% to 43,676 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 301d
  Chairman and CEO Kazimi A J bought $1,166 worth of shares (340 units at $3.43), increasing direct ownership by 0.01% to 5,699,768 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 301d
  Director Krogulski Kenneth bought $5,872 worth of shares (1,712 units at $3.43), increasing direct ownership by 0.60% to 288,345 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 332d
  Director Young Caroline bought $404 worth of shares (84 units at $4.80), increasing direct ownership by 0.26% to 32,653 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 332d
  Chairman and CEO Kazimi A J bought $807 worth of shares (168 units at $4.80), increasing direct ownership by 0.00% to 5,699,428 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 332d
  Director Jones James bought $807 worth of shares (168 units at $4.80), increasing direct ownership by 0.39% to 43,336 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 332d
  Director Krogulski Kenneth bought $4,513 worth of shares (935 units at $4.83), increasing direct ownership by 0.33% to 286,633 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 367d
  Director Krogulski Kenneth bought $4,824 worth of shares (945 units at $5.11), increasing direct ownership by 0.33% to 285,698 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 367d
  Director Jones James bought $858 worth of shares (168 units at $5.11), increasing direct ownership by 0.39% to 43,168 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 367d
  Director Young Caroline bought $429 worth of shares (84 units at $5.11), increasing direct ownership by 0.26% to 32,569 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 367d
  Chairman and CEO Kazimi A J bought $858 worth of shares (168 units at $5.11), increasing direct ownership by 0.00% to 5,699,260 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 395d
  Director Young Caroline bought $417 worth of shares (93 units at $4.48), increasing direct ownership by 0.29% to 32,485 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 395d
  Director Jones James bought $833 worth of shares (186 units at $4.48), increasing direct ownership by 0.43% to 43,000 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 395d
  Chairman and CEO Kazimi A J bought $833 worth of shares (186 units at $4.48), increasing direct ownership by 0.00% to 5,699,092 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 395d
  Director Krogulski Kenneth bought $4,635 worth of shares (1,035 units at $4.48), increasing direct ownership by 0.36% to 284,753 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 430d
  Director Young Caroline bought $384 worth of shares (74 units at $5.18), increasing direct ownership by 0.23% to 32,392 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 430d
  Director Jones James bought $881 worth of shares (168 units at $5.24), increasing direct ownership by 0.39% to 42,814 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 430d
  Chairman and CEO Kazimi A J bought $881 worth of shares (168 units at $5.24), increasing direct ownership by 0.00% to 5,698,906 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 430d
  Director Krogulski Kenneth bought $4,548 worth of shares (875 units at $5.20), increasing direct ownership by 0.31% to 283,718 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Director Young Caroline was granted 1,000 shares, increasing direct ownership by 3% to 32,318 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Director Krogulski Kenneth was granted 5,000 shares, increasing direct ownership by 2% to 282,843 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Director Jones James was granted 1,000 shares, increasing direct ownership by 2% to 42,646 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Director Galante Joseph C was granted 1,000 shares, increasing direct ownership by 2% to 61,856 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Director Brown Martin S Jr was granted 1,000 shares, increasing direct ownership by 13% to 8,500 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  SEC Form 4 filed by VP and Chief Compliance Office Herman James L

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  SEC Form 4 filed by Vice Pres Sales & Marketing Bitterman Chris T.

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  SEC Form 4 filed by Vice Pres Organizational Dev Anthony Todd M.

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
• 447d
  Chairman and CEO Kazimi A J covered exercise/tax liability with 3,558 shares, decreasing direct ownership by 0.06% to 5,698,738 units (SEC Form 4)

  4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)